• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
64.15 -1 (-1.46%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    64.00

  • Today’s High

    65.95

  • Open

    65.15

  • Perv Close

    65.10

  • 52W Low

    36.30

  • 52W High

    163.90

Key Indicators

  • P/E(TTM)

    41.43

  • Mar.Cap (₹Cr.)

    188.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    41.02

  • Debt-Equity Ratio

    -1.46

  • AGM Date

    03-Sep-2026

  • EPS

    1.55

  • P/E Ratio

    41.43

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    188.97

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.46

  • BV (₹)

    41.00

  • Sales( ₹ in Cr.)

    85.74

  • NP (in Cr.)

    5.52

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    2.40

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    189.17

  • 52 Week High

    163.90

  • 52 Week Low

    36.30

  • Price BSE

    64.0

  • Price NSE

    64.00

  • Market Capital( in Cr.)

    189.17

  • P/C Ratio

    26.50

  • P/E Ratio

    34.20

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 85.74 82.56 79.49 55.54 76.97 77.27
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 85.74 82.56 79.49 55.54 76.97 77.27
Other Income 1.17 0.88 0.92 0.12 0.95 0.96
Stock Adjustments 0.84 0.15 -1.40 -2.01 2.93 3.34
Total Income 87.75 83.59 79.01 53.65 80.85 81.57
EXPENDITURE :            
Raw Materials 53.19 55.60 56.59 39.48 53.59 52.56
Power and Fuel Cost 2.23 1.88 1.73 1.58 1.64 2.70
Employee Cost 14.62 12.45 10.09 10.65 10.88 12.04
Other Manufacturing Expenses 2.36 2.02 1.34 1.22 3.77 3.17
Selling and Administration Expenses 5.83 4.91 4.05 4.91 6.39 6.57
Miscellaneous Expenses 1.28 0.87 1.03 1.50 1.75 2.63
Employee Benefit Expenses 14.62 12.45 10.09 10.65 10.88 12.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 79.52 77.73 74.83 59.34 78.02 79.67
Operating Profit 8.23 5.86 4.17 -5.70 2.82 1.91
Interest 0.84 1.03 0.84 0.77 0.67 3.25
Gross Profit 7.39 4.83 3.33 -6.47 2.15 -1.34
Depreciation 1.59 1.60 1.77 1.72 1.49 7.09
Profit Before Tax 5.80 3.23 1.56 -8.19 0.66 -8.43
Current Tax 0.00 0.18 0.03 0.00 0.00 7.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 5.81 3.05 1.53 -8.18 0.67 -15.59
Extraordinary Items 0.29 0.02 0.01 0.01 0.26 -0.06
Adjusted Net Profit 5.52 3.03 1.52 -8.19 0.41 -15.53
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -18.73
P & L Balance brought forward -31.72 -34.78 -36.30 -28.12 -28.79 5.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -25.92 -31.72 -34.78 -36.30 -28.12 -28.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.97 1.04 0.58 -3.31 0.27 -6.31
Earnings Per Share(Adj)-Unit Curr 1.97 1.04 0.58 -3.28 0.27 -6.25
Book Value 41.02 39.06 26.49 22.98 26.31 25.99
Book Value(Adj)-Unit Curr 41.02 39.06 26.49 22.76 26.06 25.74

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 949 0.00 949 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 141,340 0.48 141,340 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,058,400 10.38 3,058,400 3
2] Non Institution
Bodies Corporate 970,318 3.29 970,318 55
Clearing Members 75,367 0.26 75,367 16
Directors of their Relatives 100 0.00 100 1
Employees 1,328 0.00 0 3
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 270,663 0.92 270,663 141
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 407,238 1.38 407,238 239
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,646,943 12.38 3,646,943 69
Individuals holding nominal share capital up to Rs. 1 lakh 5,405,029 18.35 5,404,657 10,614
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 10 0.00 10 1
Sub Total 10,898,556 37.00 10,896,856 11,150
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 11,161

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

    Krutika Mohan Rane

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 64.22 86.91 85.74 41.43 4.25
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77